Aprea Therapeutics: Q2 Earnings Insights

 

Aprea Therapeutics APRE reported its Q2 earnings results on Friday, August 12, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Aprea Therapeutics posted an EPS of $-0.99.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 29.68% drop in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Aprea Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

APRE Logo
APREAprea Therapeutics Inc
$1.71-8.06%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
7.13
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...